Diagnosis of Prostate Cancer with a Neurotensin-Bombesin Radioligand Combination-First Preclinical Results
<b>Background:</b> The concept of radiotheranostics relies on the overexpression of a biomolecular target on malignant cells to direct diagnostic/therapeutic radionuclide-carriers specifically to cancer lesions. The concomitant expression of more than one target in pathological lesions m...
Saved in:
Main Authors: | Maria Bibika (Author), Panagiotis Kanellopoulos (Author), Maritina Rouchota (Author), George Loudos (Author), Berthold A. Nock (Author), Eric P. Krenning (Author), Theodosia Maina (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands
by: Panagiotis Kanellopoulos, et al.
Published: (2020) -
Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK<sub>2</sub>R Cancer Theranostic Agents: A Preclinical Study
by: Berthold A. Nock, et al.
Published: (2022) -
Toward Stability Enhancement of NTS<sub>1</sub>R-Targeted Radioligands: Structural Interventions on [<sup>99m</sup>Tc]Tc-DT1
by: Panagiotis Kanellopoulos, et al.
Published: (2023) -
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [<sup>99m</sup>Tc]Tc-DB4 and [<sup>111</sup>In]In-SG4 in Mice Treated with Entresto
by: Panagiotis Kanellopoulos, et al.
Published: (2020) -
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
by: Berthold A. Nock, et al.
Published: (2023)